Process Package — Marketing Authorization Brazil (ANVISA) Complete framework for ANVISA medical device authorization. Covers BRH designation, classification under RDC 751/2022, Notificação vs Registro pathway selection, B-GMP certification (with MDSAP leverage), INMETRO and ANATEL conformity, and UDI/SIUD compliance (in force since July 2025). What’s included: SOP-REG-BR Marketing Authorization Brazil — full procedure: BRH designation criteria…
Process Package — Marketing Authorization USA (FDA) Complete framework for FDA medical device authorization. Covers 21 CFR 862-892 classification, the four pathways (Exempt / 510(k) / De Novo / PMA), Establishment Registration and Listing, UDI/GUDID, eSTAR submissions (mandatory for 510(k) since Oct 2023), and the FDA QMSR transition (in force Feb 2026). What’s included: SOP-REG-US…
Process Package — Marketing Authorization Japan (PMDA) Complete framework for Japanese PMDA medical device authorization. Covers DMAH designation, Foreign Manufacturer Registration (Form 63-5), JMDN code mapping, the three pathways (Todokede / Ninsho / Shonin), STED dossier, ICH E5 ethnic factor assessment, and tempu bunsho management. What’s included: SOP-REG-JP Marketing Authorization Japan — full procedure: MAH/DMAH…
Process Package — Marketing Authorization Australia (TGA) Complete framework for Australian TGA ARTG inclusion. Covers Sponsor designation, classification under TG (MD) Regulations 2002, the five conformity assessment pathways, Essential Principles (Schedule 2), AusUDID (effective 2025), and Annual Reports for ARTG-included devices. What’s included: SOP-REG-AU Marketing Authorization Australia — full procedure: Sponsor designation, classification rules, 5…
